Holen Sie sich die Stockscreener-App
77.84
3.14%
-2.52
Vorhandelsmarkt:
78.48
0.64
+0.82%
Schlusskurs vom Vortag:
$80.36
Offen:
$81.4
24-Stunden-Volumen:
9.30M
Relative Volume:
1.48
Marktkapitalisierung:
$14.13B
Einnahmen:
$1.36B
Nettoeinkommen (Verlust:
$-302.91M
KGV:
-45.30
EPS:
-1.7182
Netto-Cashflow:
$-219.93M
1W Leistung:
+31.91%
1M Leistung:
+57.70%
6M Leistung:
+59.87%
1J Leistung:
-10.60%
1-Tages-Spanne:
$75.99
$81.83
1-Wochen-Bereich:
$57.72
$81.83
52-Wochen-Spanne:
$40.77
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Firmenname
Tempus Ai Inc
Sektor
Branche
Telefon
800-976-5448
Adresse
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, TXG, HQY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
77.84 | 10.71B | 1.36B | -302.91M | -219.93M | -1.7182 |
VEEV
Veeva Systems Inc
|
260.21 | 42.48B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
56.78 | 11.62B | 13.65B | 169.86M | 412.12M | 1.0758 |
TXG
10 X Genomics Inc
|
76.60 | 8.94B | 638.78M | -22.66M | 122.18M | -0.1744 |
HQY
Healthequity Inc
|
95.14 | 7.96B | 1.34B | 230.70M | 440.96M | 2.6695 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-13 | Eingeleitet | Jefferies | Underperform |
| 2026-04-13 | Hochstufung | TD Cowen | Hold → Buy |
| 2026-02-19 | Eingeleitet | Mizuho | Outperform |
| 2026-02-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-10-21 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-10-20 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-09-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-04-21 | Eingeleitet | BTIG Research | Buy |
| 2025-02-25 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-02-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | Fortgesetzt | TD Cowen | Buy |
| 2024-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2024-12-09 | Eingeleitet | Guggenheim | Buy |
| 2024-11-11 | Herabstufung | Stifel | Buy → Hold |
| 2024-10-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-08-12 | Eingeleitet | Piper Sandler | Neutral |
| 2024-07-09 | Eingeleitet | BofA Securities | Buy |
| 2024-07-09 | Eingeleitet | JP Morgan | Overweight |
| 2024-07-09 | Eingeleitet | Longbow | Buy |
| 2024-07-09 | Eingeleitet | Loop Capital | Buy |
| 2024-07-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-07-09 | Eingeleitet | Needham | Buy |
| 2024-07-09 | Eingeleitet | Stifel | Buy |
| 2024-07-09 | Eingeleitet | TD Cowen | Buy |
| 2024-07-09 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Tempus Ai Inc Aktie (TEM) Neueste Nachrichten
Tempus AI Stock (TEM) Opinions on Recent Chart Setups and Price Targets - Quiver Quantitative
Tempus AI gets FDA clearance for pulmonary hypertension AI tool - scanx.trade
Tempus AI Stock Price: TEM Stock Chart, Market Cap & News Today - CoinGecko
TEM Stock Slips Overnight: CEO-Linked $9.6M Share Sale Puts A Cloud Over 'AI As Physician' Story - Stocktwits
H.C. Wainwright raises Tempus AI stock price target to $66 By Investing.com - Investing.com Australia
Best Artificial Intelligence Stocks To ConsiderSeptember 11th - MarketBeat
Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation - 01net
Tempus AI, Inc. Launches Effort To Build The Largest Multimodal Whole-Genome Dataset To Advance AI-Driven Healthcare Innovation - marketscreener.com
Tempus AI Building Multimodal Whole-Genome Dataset for AI Research - marketscreener.com
Tempus AI plans 100,000 whole genome sequencing dataset - investing.com
Nvidia, Snowflake, Chubb And A Health Care Stock On CNBC’s ‘Final Trades’ - Benzinga
Tempus AI (NASDAQ:TEM) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
TEM Maintained by HC Wainwright & Co. -- Price Target Raised to $66.00 - GuruFocus
H.C. Wainwright raises Tempus AI stock price target to $66 - investing.com
Tempus AI, Inc. • Robinhood Token (TEM) Price Prediction for 2026 to 2031 - Bybit
Top Artificial Intelligence Stocks To ResearchSeptember 10th - MarketBeat
Tracking Cathie Wood: Loading Up on Gene-Editing BEAM、NTLA, Trimming Googl and Tempus AI - Moomoo
Tempus AI wins up to $9.5 million ARPA-H ADVOCATE award for autonomous heart failure agent - Bitget
Tempus Secures Up to $9.5 Million in ARPA-H ADVOCATE Funding to Deploy First Autonomous AI in Cardiology - 01net
Top Artificial Intelligence Stocks To Follow NowSeptember 9th - MarketBeat
UBS Initiates Coverage on Tempus AI With Neutral Rating, $70 Price Target - Moomoo
Tempus AI (NASDAQ:TEM) Now Covered by Analysts at UBS Group - MarketBeat
TEM Stock On Track For Best Week In 4 Months Following Personalis Deal Spotlight - Stocktwits
Tempus AI (NASDAQ:TEM) Upgraded to Hold at Rothschild & Co Redburn - MarketBeat
Rothschild Redburn initiates Tempus AI stock coverage at Neutral By Investing.com - Investing.com Australia
Tempus AI (NASDAQ:TEM) Coverage Initiated at Roth Capital - MarketBeat
Rothschild Redburn initiates Tempus AI stock coverage at Neutral - investing.com
The Cure for Cancer is Becoming an Investable Opportunity: Analyst Sees $600 Million for Tempus AI - CryptoRank
Tempus AI (NASDAQ:TEM): Can Growth Outrun Rate Risks? - Kalkine Media
Weekly Recap: Intismeran win and Personalis 13% stake backs Tempus AI - TradingView
Cathie Wood's weekly recap: loads Rocket Lab, Block; cuts Palantir, Tempus AI (ARKK:BATS) - Seeking Alpha
Tempus AI, Inc. $TEM Shares Acquired by Washington Trust Advisors Inc. - MarketBeat
Public Employees Retirement System of Ohio Makes New $1.77 Million Investment in Tempus AI, Inc. $TEM - MarketBeat
Tempus AI, Inc. (TEM) Stock Analysis: Navigating Volatility With A 21.6% Revenue Growth - DirectorsTalk Interviews
Tracking Cathie Wood: Loading Up on Gene Editing and Precision Medicine, Trimming Tempus AI and Synthetic Biology - Moomoo
Wellington Management Group LLP Sells 123,748 Shares of Tempus AI, Inc. $TEM - MarketBeat
Personalized Cancer Vaccine Breakthrough Ignites Sequencing Sector, Tempus AI's Personalis Bid Faces Rivalry Speculation - finance.biggo.com
Tempus AI Stock (TEM) Opinions on Analyst Upgrades and Personalized Medicine Momentum - quiverquant.com
Tempus to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - Yahoo Finance
Tempus AI Director Jennifer A. Doudna Sells 676 Shares Under Rule 10b5-1 Plan - Kalkine Media
Tempus AI Data CEO Ryan Fukushima's Spouse Executes $30,846 Share Sale via 10b5-1 Plan - Kalkine Media
Tempus AI (TEM) CEO's spouse sells 30,846 shares under trading plan - Stock Titan
Tempus AI (TEM) director’s stock sale follows preset plan - Stock Titan
Tempus AI (TEM) director sells 676 shares under preset plan - Stock Titan
Artificial Intelligence Stocks Worth WatchingSeptember 3rd - MarketBeat
Tempus AI Got an $80 Target and 28% Upside Call. Is Wall Street Underestimating Its Healthcare Data Moat? - finance.yahoo.com
Tempus AI's Data Business Is Priced Like a Vendor, Not a Platform, Analyst Says - Benzinga
Cantor Fitzgerald initiates Tempus AI stock with overweight rating By Investing.com - Investing.com Australia
Artificial Intelligence Stocks To Watch TodaySeptember 2nd - MarketBeat
Tempus AI gains as Cantor issues new Overweight on Data and applications segment - Seeking Alpha
Tempus AI Director Nadja West Sells 3,000 Shares for $207,000 - The Motley Fool
Finanzdaten der Tempus Ai Inc-Aktie (TEM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Tempus Ai Inc-Aktie (TEM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Bartolucci Ryan M | Chief Accounting Officer |
Sep 17 '26 |
Sale |
75.00 |
7,062 |
529,650 |
60,804 |
| Polovin Andrew | EVP, Chief Legal Officer |
Sep 17 '26 |
Sale |
75.00 |
2,951 |
221,325 |
135,189 |
| Fukushima Ryan | CEO, Data |
Sep 16 '26 |
Sale |
70.00 |
700 |
49,000 |
15,874 |
0.32%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):